Skip to content
Menu

Assembly Biosciences Presents Phase 1b Data For ABI-5366 And ABI-1179 At ESCMID Global

Benzinga Newsdesk 7 months ago

BiotechNewsEventsGeneral

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

– Additional Phase 1b data for ABI-5366, including results from monthly dosing cohort, selected for oral presentation –– Phase 1b data from ABI-1179 accepted for late-breaker poster presentation –

– Additional Phase 1b data for ABI-5366, including results from monthly dosing cohort, selected for oral presentation –

– Phase 1b data from ABI-1179 accepted for late-breaker poster presentation –

Read at benzinga.com